Present situation about COVID-19 patients with myocarditis: how to protect the at-risk crowd

Xiaolan Zhao

doi:10.1117/12.3013055

8 January 2024 Present situation about COVID-19 patients with myocarditis: how to protect the at-risk crowd

Xiaolan Zhao

Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 1292439 (2024) https://doi.org/10.1117/12.3013055
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom

Abstract

In today's COVID-19 epidemic, many articles have studied the pathogenic mechanism of SARS-CoV-2 and found that ACE2 is related to the entry of SARS-CoV-2 into cells, and ACE2 is commonly distributed in many organs of the human body, which shows that SARS-CoV-2 It may bring about multi-organ injury. More and more articles begin to focus on diseases other than lung diseases in COVID-19 patients. As a disease directly related to mortality, myocarditis has also received extensive attention. At present, the pathogenesis of myocarditis has not been clarified, and there are still some disputes about its diagnosis and therapy. Since the birth of the COVID-19 vaccine, its safety has also been a hot topic of discussion, and in some cases, COVID-19 vaccines have been found to cause myocarditis. And the correlation and danger factors of myocarditis and vaccines are also within the scope of discussion. This study aims to summarise the current situation of myocarditis induced by COVID-19, and discuss the mechanism and treatment of myocarditis. This study looks for risk factors and at-risk groups of myocarditis induced by COVID-19, and discuss the possibility of preventing myocarditis from the direction of protecting at-risk groups.

(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.

Citation Download Citation

Xiaolan Zhao "Present situation about COVID-19 patients with myocarditis: how to protect the at-risk crowd", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 1292439 (8 January 2024); https://doi.org/10.1117/12.3013055

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
9 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

COVID 19

Heart

Cardiovascular disorders

Proteins

Viruses

Pathogens

Pulmonary disorders

Show All Keywords

Keywords/Phrases

Search In:

Publication Years